Videos

This new, 3-week exercise series features 9 workouts of about 20 minutes each and is designed especially for people who are going through or recovering from treatment, preparing for surgeries, or regaining mobility after surgery. See the full playlist.

Do you have a family history of or an inherited risk to breast cancer or ovarian cancer? Have you heard of BRCA mutation? Watch this video to learn how genetic testing can significantly reduce your risk of a late-stage cancer diagnosis, what screenings insurance might cover, and how to talk to your doctor about your breast cancer risk. Learn about the signs and symptoms of breast and ovarian cancer so you know what to watch out for. Thank you to Susan M. Domchek, MD from the Basser Center for BRCA at Penn Medicine.

From managing “scanxiety,” depression, and other emotional concerns to the benefits of getting out of the house, even planning a vacation, a group of women living with metastatic breast cancer engage in real and sometimes raw conversation about how they cope and find comfort and joy in making plans. Learn more about this video series.

From letting go of people in their lives who don’t “get it” to connecting to people who do (be it family, friends, or in an organized support group), a diverse group of women open up about the importance of a community of support while navigating the complex medical, emotional, and financial challenges that come with a metastatic breast cancer diagnosis. Learn more about this video series.

Gathered together in the kitchen and the living room, a group of women from various walks of life share their personal stories living with metastatic breast cancer, including how they manage work, parenting, and daily life, and offer insights and tips to help others find a way forward. Learn more about this video series.

Shonté was diagnosed with metastatic breast cancer in 2015 at the age of 31. When she experienced significant impacts to her sexual health after hormone therapy, she identified a deep failing in health care professionals’ communication with their patients. See other stories in this video series.

Priscila was diagnosed with early-stage breast cancer in 2011. She speaks about the changes in body image and sexuality she experienced after her mastectomy, and how she has navigated a newfound pleasure in intimacy. See other stories in this video series.

Side effect management is crucial to living well with metastatic breast cancer. In this hour-long Q & A, conference attendees asked questions of our expert panel to help get the information and tools needed to effectively manage the physical and emotional impact of metastatic breast cancer and its treatments. Panelists include Don S. Dizon, MD; Pamela Ginsberg, PhD; and Heather Wright, ND, FABNO.

In this video, learn about the foods and eating strategies that can enhance your breast cancer treatment, boost your immune system, lessen inflammation in the body, and optimize your nutrition. Gain strategies for eating well despite specific diet or nutritional challenges, food sensitivities, or preferences, and participate in a food prep demonstration!

We created a video series featuring women diagnosed with breast cancer, along with mental health experts, to help you care for yourself and thrive when you finish active treatment. In these videos you will learn about tools for processing your emotions, making meaning, accepting your changed body, and managing fear of recurrence.

This video series is for people diagnosed with early-stage breast cancer.

A breast cancer diagnosis can affect your sexuality in many ways. In this video series, young women offer candid insights about dating, body image, libido, intimate relationships, communication with health care providers, remedies, and more. This is Anna’s story.

Understanding your breast cancer diagnosis, treatment, and potential side effects can be overwhelming. In this video, Reshma L. Mahtani, DO, answers questions about breast cancer treatment options, recent drug approvals, immunotherapy, as well as symptoms and side effects for early stage hormone receptor-positive, HER2-positive, and triple-positive breast cancer.